Spectral Medical Inc
F:SD4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Spectral Medical Inc
F:SD4
|
CA |
|
A
|
Asahi Group Holdings Ltd
XMUN:ABW
|
JP |
Intrinsic Value
The intrinsic value of 
Spectral Medical Inc (SD4) under the Base Case is 0.43 EUR per share.
Compared with the current market price of 0.55 EUR, the stock appears
Overvalued by 21% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Spectral Medical Does
Spectral Medical Inc. is a Canadian medical device and diagnostics company focused on treating and identifying severe blood infection complications in critically ill patients. Its main product is a blood purification therapy used in intensive care to remove endotoxin, a harmful toxin linked to septic shock. It also develops the tools needed to identify patients who may benefit from that therapy, including the Endotoxin Activity Assay used in hospital laboratories.
- Headquarters
- Canada CA
- Employees
- 29
- IPO date
- Jul 16, 1992
Revenue & Expenses Breakdown
Spectral Medical Inc
Earnings Waterfall
Spectral Medical Inc
The intrinsic value for Spectral Medical Inc (SD4) under the Base Case is 0.43 EUR.
Compared with the current market price of 0.55 EUR, the stock appears Overvalued by 21% .